Newcastle pharmacy experts work with Italian biotech lab to provide access to sight-saving treatment across England
Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency
Holostem and Chiesi Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)
